Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 18, 2016. The document serves as a transaction notification regarding a Person Discharging Managerial Responsibilities (PDMR) rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to a specific share transaction notification.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details a single transaction involving the acquisition of 17 Ordinary Shares by Mrs. V A Whyte (Company Secretary) on July 15, 2016, at a price of £16.34 per share. This acquisition resulted from the re-investment of dividends paid on July 14, 2016, within an Individual Savings Account (ISA).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the identity of the PDMR involved: Mrs. V A Whyte, Company Secretary.
- Confirm the transaction nature: Dividend re-investment (DRIP) within an ISA.
- Note the transaction volume: 17 Ordinary Shares.
- Confirm the transaction date: July 15, 2016.
- Verify the execution venue: London Stock Exchange (XLON).